Paxlovid and Pregabalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paxlovid (nirmatrelvir; ritonavir) and Pregabalin (pregabalin). Common drug interactions include sleep disorder among females and disease recurrence among males.

The phase IV clinical study analyzes what interactions people have when they take Paxlovid and Pregabalin. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Paxlovid?

Paxlovid has active ingredients of nirmatrelvir; ritonavir. eHealthMe is studying from 38,422 Paxlovid users. Check the latest studies of Paxlovid.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,071 Pregabalin users. Check the latest studies of Pregabalin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

91 people who take Paxlovid and Pregabalin together, and have interactions are studied.

Paxlovid and Pregabalin drug interactions.

What are the common drug interactions of Paxlovid and Pregabalin, by gender? *:

female:

  1. Sleep disorder
  2. Abnormal dreams
  3. Asthenia (weakness)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Hallucination (an experience involving the perception of something not present)
  6. Nightmare (unpleasant dream)
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Abdominal pain upper
  9. Asthma
  10. Back pain

male:

  1. Disease recurrence
  2. Blood creatine phosphokinase increased
  3. Back pain
  4. Blood albumin decreased
  5. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  6. Eye pain
  7. Pruritus (severe itching of the skin)
  8. Rash papulosquamous (a condition which presents with both papules and scales, or both scaly papules and plaques)
  9. Renal pain (kidney pain)
  10. Aphasia (damage to the parts of the brain that control language)

What are the common drug interactions of Paxlovid and Pregabalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Urinary tract infection

20-29:

n/a

30-39:

  1. Drug ineffective
  2. Dysgeusia (disorder of the sense of taste)
  3. Headache (pain in head)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

40-49:

  1. Disease recurrence
  2. Dysgeusia (disorder of the sense of taste)
  3. Dyspnoea (difficult or laboured respiration)
  4. Throat tightness
  5. Cellulitis (infection under the skin)
  6. Retching (strong involuntary effort to vomit)
  7. Rotator cuff repair
  8. Sleep disorder
  9. Chest discomfort
  10. Bradycardia (abnormally slow heart action)

50-59:

  1. Chest discomfort
  2. Decreased appetite
  3. Drug ineffective
  4. Dyspepsia (indigestion)
  5. General physical health deterioration (weak health status)
  6. Leukocytosis (increased white blood cells)
  7. Leukopenia (less number of white blood cells in blood)
  8. Loss of consciousness
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

60+:

  1. Disease recurrence
  2. Blood creatine phosphokinase increased
  3. Hypovolaemic shock (shock caused by severe blood or fluid loss)
  4. Inflammation
  5. Myelosuppression (a decrease in the production of blood cells)
  6. Pruritus (severe itching of the skin)
  7. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  8. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  9. Blood albumin decreased
  10. Blood pressure decreased

What are the existing conditions these people have? *

  1. Neuralgia (pain in one or more nerves): 10 people, 10.99%
  2. Pain: 8 people, 8.79%
  3. Neuropathy Peripheral (surface nerve damage): 8 people, 8.79%
  4. High Blood Pressure: 7 people, 7.69%
  5. Depression: 7 people, 7.69%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 5.49%
  7. High Blood Cholesterol: 5 people, 5.49%
  8. Diabetes: 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Paxlovid and Pregabalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Paxlovid and Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paxlovid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paxlovid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on nirmatrelvir; ritonavir and pregabalin (the active ingredients of Paxlovid and Pregabalin, respectively), and Paxlovid and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: